Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han T Cun

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Gynecologic Oncology|November 25, 2025
Radiation therapy for the gynecologic oncologistHan T Cun, Sabrina M Bedell, John Kimball, et al.
Gynecologic Oncology|August 10, 2024
Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinomaHan T Cun, Laurence Bernard, Karin Teien Lande, et al.
Gynecologic Oncology|October 21, 2023
Isolated vaginal recurrence in women with stage I endometrial cancerEric Rios-Doria, Han T Cun, Olga T Filippova, et al.
Cancers|February 9, 2021
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. <i>Cancers</i> 2020, <i>12</i>, 2436Wen Hu, Li Zhang, Sammy Ferri-Borgogno, et al.
Cancers|September 2, 2020
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant PhenotypeWen Hu, Li Zhang, Sammy Ferri-Borgogno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2022
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-AnalysisMiranda P Steenbeek, Majke H D van Bommel, Johan Bulten, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Gynecologic Oncology|November 25, 2025
Radiation therapy for the gynecologic oncologistHan T Cun, Sabrina M Bedell, John Kimball, et al.
Gynecologic Oncology|August 10, 2024
Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinomaHan T Cun, Laurence Bernard, Karin Teien Lande, et al.
Gynecologic Oncology|October 21, 2023
Isolated vaginal recurrence in women with stage I endometrial cancerEric Rios-Doria, Han T Cun, Olga T Filippova, et al.
Cancers|February 9, 2021
Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. <i>Cancers</i> 2020, <i>12</i>, 2436Wen Hu, Li Zhang, Sammy Ferri-Borgogno, et al.
Cancers|September 2, 2020
Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant PhenotypeWen Hu, Li Zhang, Sammy Ferri-Borgogno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2022
Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-AnalysisMiranda P Steenbeek, Majke H D van Bommel, Johan Bulten, et al.
Pageof 1